SS Innovations International (SSII) Record Q2 Revenue Signals Continued Momentum for SSi Mantra Robotic Surgery Platform

• SS Innovations, developer of innovative surgical robotic technologies, reported record second-quarter revenue of $13.9 million, up 39.4% year over year.
• First-half revenue reached $25.0 million, a 65.6% increase from the same period in 2025.
• The company’s SSi Mantra installations rose 30.4% to 30 systems during the quarter.
• The installed base reached 224 SSi Mantra systems across 12 countries, with 12,272 cumulative surgeries performed.
• U.S. and European regulatory milestones could become important catalysts, with the company targeting FDA clearance by the first quarter of 2027 and EU CE marking by the end of 2026.
• The company’s telesurgery achievements are extending the clinical profile of SSi Mantra, while system installations remain the primary commercial growth driver.

LOS ANGELES, CA - August 19, 2026 (NEWMEDIAWIRE) - SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, delivered another quarter of rapid top-line growth as demand for its SSi Mantra surgical robotic system continued to expand. The company reported second-quarter 2026 revenue of $13.9 million, an increase of 39.4% from $10.0 million a year earlier. Gross profit increased 20.0% to $7.1 million, although gross margin declined to 50.9% from 59.1% in the year-earlier quarter (https://nnw.fm/zxrT1).

The stronger comparison comes over the first six months of the year. Revenue reached $25.0 million, up 65.6% from $15.1 million in the first half of 2025. Gross profit increased 77.5% to $12.4 million, while first-half gross margin improved to…

Read More

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

Forward Looking Statements

Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law

View the original release on www.newmediawire.com

This contant was orignally distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is SS Innovations International (SSII) Record Q2 Revenue Signals Continued Momentum for SSi Mantra Robotic Surgery Platform.